The goal of this study is to compare the effectiveness and safety of two hemoglobin F inducer. This is single centered interventional pilot study is to compare the efficacy and safety parameters in beta thalassemia patients. As this is a pilot study, the investigator took a small number of patients. The Sample size was calculated by the World health organization sample size calculator. After screening 39 patients and 24 patients were eligible for enrollment in this study. The main objective was to evaluate safety of both drugs in genetic disorder like thalassemia. for safety evaluation, hematological parameters were evaluated that includes total bilirubin , indirect bilirubin, Serum Glutamate Pyruvate Transaminase, serum glutamic-oxaloacetic transaminase, urea, creatinine and lactate dehydrogenase were monitored . Moreover to evaluate the efficacy of drug, hematological parameters that includes hemoglobin, red blood cells , nucleated red blood cells , reticulocytes count, Red blood cells indices ( mean corpuscular hemoglobin, mean corpuscular volume and mean corpuscular hemoglobin concentration) , white blood cells and platelets were done. Another important parameters to evaluate the efficacy of hemoglobin F inducer is transfusion frequency. Test were done at baseline and after completion of study means after 06 months.
Age range
10 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
comparison of hemoglobin
Timeframe: 06 months
comparison of red blood cells
Timeframe: 06 months
comparison of Mean corpuscular volume
Timeframe: 06 months
comparison of Mean Corpuscular Hemoglobin
Timeframe: 06 months
comparison of Mean Corpuscular Hemoglobin concentration
Timeframe: 06 months
comparison of Indirect bilirubin
Timeframe: 06 months
comparison of Total Bilirubin
Timeframe: 06 months
comparison of Serum glutamic pyruvic transaminase
Timeframe: 06 months
comparison of glutamic-oxaloacetic transaminase
Timeframe: 06 months
comparison of white blood cells
Timeframe: 06 months
comparison of platelets
Timeframe: 06 months
comparison of urea
Timeframe: 06 months
comparison of creatinine
Timeframe: 06 months
comparison of Lactate dehydrogenase baseline and after the completion of study.
Timeframe: 06 months
comparison of tranfusion frequency baseline and after the completion of study.
Timeframe: 06 months